oncology platform Applications
-
IGX Platform Software for Immuno-Oncology
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. Immune repertoire analysis provides accurate, sensitive, and rapid detection of antibody sequences in panning rounds or exposured animal models, accelerating the discovery of ...
By Enpicom B.V. based in s-Hertogenbosch, NETHERLANDS.
-
NK-cell Therapy - Ushering in the Future of NK-cell Therapy
Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases. Today, we know that NK cells not only detect and identify malignant cancer cells, but they also induce cancer cell death and even help trigger a broader adaptive immune ...
By Kiadis Pharma NV based in Amsterdam, NETHERLANDS.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you